Educational sessions in pharmacovigilance: What do the doctors think? - Wikidata - wikimedia - TriplyDB

Educational sessions in pharmacovigilance: What do the doctors think?

Educational sessions in pharmacovigilance: What do the doctors think?

http://www.wikidata.org/entity/Q30992133

about

Japanese Physicians' Views on Drug Post-Marketing Surveillance.How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions.Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.

P2860

Q36223753-49C3908A-D472-4564-BF31-40E36819CE55 Q37976659-CEED028F-C243-4C1F-9F57-DD86181577F9 Q48300426-50F2F600-2610-46DB-9F80-626101163D55

P2860

Educational sessions in pharmacovigilance: What do the doctors think?

http://www.wikidata.org/entity/Q30992133

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Educational sessions in pharmacovigilance: What do the doctors think?

@ast

Educational sessions in pharmacovigilance: What do the doctors think?

@en

type

label

Educational sessions in pharmacovigilance: What do the doctors think?

@ast

Educational sessions in pharmacovigilance: What do the doctors think?

@en

prefLabel

Educational sessions in pharmacovigilance: What do the doctors think?

@ast

Educational sessions in pharmacovigilance: What do the doctors think?

@en

P1433

Q30992133-EB83797A-DAA2-4978-AA48-62CE5A82F4EC

P1476

Q30992133-2FEDF8BA-90FF-4F79-AF88-14F0400EA835

P2093

Q30992133-0052CCDC-A248-46A3-B5B5-E8A405D6310B

Q30992133-0C0069DD-575D-41CD-A776-C3992B2B94E4

Q30992133-49C5C9FE-4A49-48BC-A958-B92158095B5C

Q30992133-B3355034-271F-4023-B3C6-5E366D2CCA06

Q30992133-BF8E22BD-0601-4275-B12B-401BFE9E595D

P2860

Q30992133-01DDEB62-F279-45FF-BE68-56F5A9D99973

Q30992133-0B63AB74-4A7F-4F05-B02F-5FDE327DD9E6

Q30992133-1D7AE407-3E16-4FAD-8D6B-537BCF09D034

Q30992133-2620D9CC-E7C1-4D7A-88C9-46301A6639FA

Q30992133-26F522F7-F749-4100-90B6-E22C0BBF939E

Q30992133-284ED1E1-2AB0-453B-9336-DED2DBB0749A

Q30992133-3407B8F0-9B17-476F-8F30-AB1129FA82F9

Q30992133-4E5A48AC-1510-4829-A85F-C3F9F6061EBD

Q30992133-753D0929-8224-4FFA-87B6-F2DC0C162332

Q30992133-847B7147-CAD8-4BA4-B347-140FAFDE8544

P2888

Q30992133-59D660F8-CCEC-48B9-9CB3-1EE15C34E815

P304

Q30992133-CFBD751C-073E-4F98-891D-84B4437CFFE6

P31

Q30992133-5F245B30-3972-4BBE-AC11-33C3DD1DB9EE

P356

Q30992133-62E1FBD1-99FD-4C8E-BD1E-AD5B0F478D67

P478

Q30992133-492727C8-1DD9-45FB-9B28-D471B9A3E6B6

P50

Q30992133-7182FF8B-18FD-40C3-B848-3775CF3CF573

Q30992133-E3CD6209-A6A4-4740-92EA-D87BF3D8DF3C

P577

Q30992133-76B10A16-A38E-4027-8125-36603B177AE4

P5875

Q30992133-E926D8CC-95C5-40A6-8B49-F529CD76F411

P6179

Q30992133-692DD33F-017E-4A74-8912-0A2244905F66

P698

Q30992133-98D1AFA8-66D4-4E90-800C-8105E293D2AC

P932

Q30992133-5760448C-6C93-4DE6-BDB3-1A0C0955352C

P356

1756-0500-3-311

P1433

BMC Research Notes

P1476

Educational sessions in pharmacovigilance: What do the doctors think?

@en

P2093

Antonia Agustí

http://www.w3.org/2001/XMLSchema#string

Cristina Aguilera

http://www.w3.org/2001/XMLSchema#string

Gloria Cereza

http://www.w3.org/2001/XMLSchema#string

Immaculada Danés

http://www.w3.org/2001/XMLSchema#string

Josep Maria Arnau

http://www.w3.org/2001/XMLSchema#string

P2860

Is there still a role for spontaneous reporting of adverse drug reactions?

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

Under-reporting of adverse drug reactions in general practice

Under-reporting of adverse drug reactions : a systematic review.

Determinants of under-reporting of adverse drug reactions: a systematic review.

Expectations of general practitioners and specialist doctors regarding the feedback received after reporting an adverse drug reaction.

Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.

Reporting of adverse drug reactions by hospital doctors and the response to intervention.

P2888

1756-0500-3-311

P304

311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-3-311

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Consuelo Pedrós

Antonio Vallano Ferraz

P577

2010-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47811238

http://www.w3.org/2001/XMLSchema#string

P6179

1011072176

http://www.w3.org/2001/XMLSchema#string

P698

21083899

http://www.w3.org/2001/XMLSchema#string

P932

2993731

http://www.w3.org/2001/XMLSchema#string